| Financial Year |
March 31 2023 |
| Monetary Funds |
728,525,284.21 |
| Held-for-trading Financial Assets |
47,600,000.00 |
| Notes Receivable |
254,285,896.36 |
| Accounts Receivable |
603,408,290.64 |
| Advances to Suppliers |
100,852,701.38 |
| Other Receivables |
118,397,390.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
435,928,049.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,771,831.41 |
| Total Current Assets |
2,375,128,708.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,500,459.19 |
| Long-term Equity Investment |
225,376,477.37 |
| Investment Properties |
1,753,371.10 |
| Fixed Assetes |
3,254,692,433.01 |
| Under-construction Projects |
106,485,312.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
834,875,350.05 |
| R&D expenses |
-- |
| Goodwill |
40,782,404.92 |
| Long-Term Deferred and Prepaid Expenses |
8,774,231.24 |
| Deferred Income Tax Assets |
141,389,977.66 |
| Other Non-Current Assets |
134,798,125.77 |
| Sub-Total of Non-Current Assets |
5,026,616,336.26 |
| Total Assets |
7,401,745,045.08 |
| Short-Term Loans |
1,456,111,722.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,000,000.00 |
| Accounts Payable |
807,538,442.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
113,004,337.22 |
| Taxes Payable |
70,716,161.81 |
| Interest Payable |
31,148,208.32 |
| Dividend Payable |
18,598,885.59 |
| Other payables |
402,348,121.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
807,142,840.77 |
| Other Current Liabilities |
202,858,971.26 |
| Sub-Total of Current Liabilities |
4,131,933,242.41 |
| Long-term Loans |
416,779,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
228,967,967.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,860,744.63 |
| Deferred Income Tax Liabilities |
135,936,573.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
904,596,058.84 |
| Total Liabilities |
5,036,529,301.25 |
| Paid-In Capital(Or Share Stock) |
390,943,834.00 |
| Capital Surplus |
565,979,690.58 |
| Surplus Reserve |
119,973,357.37 |
| LESS:Treasury Stock |
49,384,360.00 |
| Undistributed Profits |
349,111,809.74 |
| Minority Stockholder's Interest |
895,388,159.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,469,827,584.76 |
| Owner's Equity（Stockholder's Equity） |
2,365,215,743.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,401,745,045.08 |
